Navigating the landscape of end-of-life care and access to medications like Nembutal in New South Wales, NSW, requires a careful comprehension of the complex legal system. Currently, this powerful sedative does not have a approved place on the Pharmaceutical Benefits Scheme (PBS) and is therefore not routinely prescribed by clinical professionals.